Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05633134

Precision Preoperative Embolization of Pelvic Tumors to Improve Surgical Outcomes

Conditions: Embolization, Pelvic Tumor

Sex: All
Ages: 18 Years – 70 Years
Phase: NA
Enrollment: 120
Sponsor: Peking University People's Hospital

Summary

The main purpose of this study is to assess the efficacy of precision preoperative embolization in decreasing operative blood loss, reducing surgical complications in pelvic tumor surgery. Furthermore the study aims at describing the vascularity in a series of pelvic tumors, and to correlate this with perioperative blood loss.

Eligibility Criteria

Inclusion Criteria:Primary or metastatic pelvic tumorConfirmed by contrast-enhanced magnetic resonance imaging (MRI) or computed tomography (CT) of the pelvicPlanned surgical resectionExclusion Criteria:Contrast medium allergyUncontrolled or concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05633134). StuddyBuddy aggregates publicly available trial information.